Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
266.22
+5.71 (+2.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about United Therapeutic
< Previous
1
2
3
Next >
United Therapeutics Corporation Reports First Quarter 2023 Financial Results
May 03, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023
April 26, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings
April 18, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023
February 15, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 02, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
December 08, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
November 02, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference
November 01, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy
October 31, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022
October 26, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting
October 14, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
October 11, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report
September 12, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation
August 31, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022
August 24, 2022
From
United Therapeutics Corporation
Via
Business Wire
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
Via
Investor Brand Network
Exposures
Product Safety
United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
August 03, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Second Quarter 2022 Financial Results Before the Market Opens on Wednesday, August 3, 2022
July 27, 2022
From
United Therapeutics Corporation
Via
Business Wire
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill...
Via
FinancialNewsMedia
Exposures
Product Safety
United Therapeutics Provides an Update on Its Organ Printing Programs
June 06, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Jefferies Healthcare Conference
June 03, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces FDA Approval of Tyvaso DPI™
May 24, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Reports First Quarter 2022 Financial Results
May 04, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International Conference
April 29, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022
April 27, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation
April 06, 2022
From
United Therapeutics Corporation
Via
Business Wire
Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease
February 28, 2022
PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world
Via
Newswire.com
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.